Premium
Improved response rates shown with neoadjuvant and adjuvant pembrolizumab for triple‐negative breast cancer with lymph node involvement
Author(s) -
Printz Carrie
Publication year - 2020
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.32894
Subject(s) - medicine , pembrolizumab , breast cancer , chemotherapy , triple negative breast cancer , taxane , oncology , lymph node , cancer , anthracycline , neoadjuvant therapy , surgery , immunotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom